CN Patent

CN102816113A — 用于治疗和预防疾病和疾病症状的氟代ω-羧芳基二苯基脲

Assigned to Bayer Pharmaceuticals Corp · Expires 2012-12-12 · 13y expired

What this patent protects

本发明涉及用于治疗和预防疾病和疾病症状的氟代ω-羧芳基二苯基脲，具体地，本发明涉及式(I)的化合物： (I)其盐、其前药、其代谢物、含有这种化合物的药物组合物，以及这种化合物和组合物在治疗由raf、VEGFR、PDGFR、p38和flt-3介导的疾病中的应用。

USPTO Abstract

本发明涉及用于治疗和预防疾病和疾病症状的氟代ω-羧芳基二苯基脲，具体地，本发明涉及式(I)的化合物： (I)其盐、其前药、其代谢物、含有这种化合物的药物组合物，以及这种化合物和组合物在治疗由raf、VEGFR、PDGFR、p38和flt-3介导的疾病中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102816113A
Jurisdiction
CN
Classification
—
Expires
2012-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharmaceuticals Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.